A 64-year-old with advanced prostate cancer underwent robotic surgery after hormonal therapy, achieving successful tumour ...

ATLANTA, GA / ACCESS Newswire / April 17, 2026 / Advanced Urology , a leading provider of comprehensive urologic care in the ...

A prostate cancer patient from Worthing has become the first in Sussex to receive an innovative new treatment. Darius Aibara, ...

The experimental medicine NXP800 could help men who are no longer responding to treatment Laura Donnelly is the Health Editor for The Telegraph, leading award-winning coverage on the NHS, medical ...

Sussex patients with advanced prostate cancer are now receiving highly personalised and innovative new treatments at Royal Sussex County Hospital.

Patients could one day be treated with the new combination of drugs. Sign up for the top news stories every day to keep you informed with what's going on in the West Midlands. A double-pronged attack ...

An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose treatment has stopped working, according to scientists. Experts hailed ...

For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to luteinizing hormone-releasing hormone (LHRH) agonists as a ...

An innovative drug trialled for tackling certain cancers holds potential benefits for advanced prostate cancer patients whose current treatments have failed, scientists say. The breakthrough has been ...

Thousands of men with advanced prostate cancer are set to be offered a pill which can lower the risk of death by a third. Experts claim the drug, olaparib, offers a lifeline to men with the most ...

An appeal panel upheld a string of complaints which came from the drug’s manufacturer, prostate cancer specialists, and charities Dominic Penna is The Telegraph's Senior Political Correspondent, ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone therapy enzalutamide. A study found that giving men access to cancer screening ...